G D H Pharma Private Limited
About G D H Pharma Private Limited
Data last updated:
G D H Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 May 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL2000PTC105701. Its GSTIN is 07AABCG5110F1Z6 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.51 Lakh. It is led by directors Girish Kumar and Gunjan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 61 Mansa Ram Parkuttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.17 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹2.72 Lakh (net margin 0.4%) and EBITDA of ₹4.3 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 12% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
G D H Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 61 Mansa Ram Parkuttam Nagar, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of G D H Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of G D H Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of G D H Pharma Private Limited, buy the company report.
Financials of G D H Pharma Private Limited
FY 2025 filings availableG D H Pharma Private Limited reported revenue of ₹6.17 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 233% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of G D H Pharma Private Limited, buy the company report.
Board of directors of G D H Pharma Private Limited
G D H Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gunjan | Additional Director | 02 Dec 2022 | 3 Years 11 Months | Current |
| Girish Kumar | Director | 15 May 2000 | 26 Years 5 Months | Current |
Peer comparison
G D H Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ursapharm India Private Limited | ₹6.22 Cr (FY 2024) | -23.0% | New Delhi, Delhi, India | |||
| G D H Pharma Private Limitedthis company | ₹6.17 Cr (FY 2025) | ₹2.72 Lakh | 0.4% | -9.0% | Delhi, India | |
| Mitis Biomedics Limited | ₹6.16 Cr (FY 2024) | 22.0% | Delhi, India | |||
| Anabiosis Medisciences Limited | ₹6.16 Cr (FY 2023) | -13.0% | Ahmedabad, Gujarat, India | |||
| Webcon Labs Private Limited. | ₹6.15 Cr (FY 2024) | 15.0% | New Delhi, Delhi, India | |||
| Mayfair Tie-Up Private Limited. | ₹6.15 Cr (FY 2019) | -49.0% | Asansol, West Bengal, India |
To see the full peer comparison of G D H Pharma Private Limited, buy the company report.
Auditor
G D H Pharma Private Limited is audited by MITTAL VARSHNEY & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITTAL VARSHNEY & CO | FY 2020 | 010578C |
Shareholding
The shareholding of G D H Pharma Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of G D H Pharma Private Limited, buy the company report.
Legal cases
G D H Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Ozone Pharmaceuticals Ltd Through Its Authorized Representative SH Rachit Manchanda | Pending |
To see the full case history of G D H Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for G D H Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
G D H Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCG5110F1Z6 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of G D H Pharma Private Limited, buy the company report.
Recent activity
G D H Pharma Private Limited has 3 board changes on record since 2000: 2 appointments and 1 cessation. The latest: Mukesh Kumar Gupta ceased to be Director on 12 Dec 2022.
Frequently asked questions
G D H Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 May 2000 (26+ years old) and is registered under CIN U74899DL2000PTC105701.
G D H Pharma has 2 current directors:
- Gunjan - Additional Director
- Girish Kumar - Director
The latest financial statements of G D H Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of G D H Pharma is 07AABCG5110F1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of G D H Pharma is U74899DL2000PTC105701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
G D H Pharma has 1 court case on record: 1 filed against it. 1 is pending.
G D H Pharma was incorporated on 15 May 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of G D H Pharma by revenue are Ursapharm India Private Limited, Mitis Biomedics Limited, Anabiosis Medisciences Limited, Webcon Labs Private Limited, Mayfair Tie-Up Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Mukesh Kumar Gupta ceased to be Director on 12 Dec 2022. Gunjan was appointed as Additional Director on 02 Dec 2022. Girish Kumar was appointed as Director on 15 May 2000.
The registered office of G D H Pharma is at D – 61 Mansa Ram Parkuttam Nagar, Delhi, India – 110059.
G D H Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
